Your browser doesn't support javascript.
loading
Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies.
Pariser, David; Frankel, Ellen; Schlessinger, Joel; Poulin, Yves; Vender, Ronald; Langley, Richard G; Meng, Xiangyi; Guana, Adriana; Nyirady, Judit.
Affiliation
  • Pariser D; Eastern Virginia Medical School and Virginia Clinical Research, Inc., Norfolk, VA, USA. dpariser@pariserderm.com.
  • Frankel E; Clinical Partners, LLC, Johnston, RI, USA.
  • Schlessinger J; Advanced Skin Research Center, Omaha, NE, USA.
  • Poulin Y; Laval University and Centre Dermatologique du Québec Métropolitain, Québec, QC, Canada.
  • Vender R; Department of Medicine, McMaster University, and Dermatrials Research Inc., Hamilton, ON, Canada.
  • Langley RG; Dalhousie University, Halifax, NS, Canada.
  • Meng X; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Guana A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Nyirady J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Dermatol Ther (Heidelb) ; 8(1): 17-32, 2018 Mar.
Article in En | MEDLINE | ID: mdl-29218492
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: Dermatol Ther (Heidelb) Year: 2018 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: Dermatol Ther (Heidelb) Year: 2018 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza